1. Antihypertensives and coronary risk

   Newsletter Article 12 February 2013 Pages: 2 - 2

2. Interaction potential of antibiotics

   Newsletter Article 12 February 2013 Pages: 2 - 3

3. ACE inhibitors

   Newsletter Article 12 February 2013 Pages: 3 - 3

4. Allopurinol see Aluminium hydroxide interaction

   Newsletter Article 12 February 2013 Pages: 3 - 3

5. Aluminium hydroxide interaction

   Newsletter Article 12 February 2013 Pages: 3 - 3

6. Antacids see Sucralfate

   Newsletter Article 12 February 2013 Pages: 4 - 4

7. Azathioprine

   Newsletter Article 12 February 2013 Pages: 4 - 4

8. Bupivacaine

   Newsletter Article 12 February 2013 Pages: 4 - 4

9. Captopril

   Newsletter Article 12 February 2013 Pages: 4 - 4

10. Carbamazepine interaction

    Newsletter Article 12 February 2013 Pages: 4 - 4

11. Carbenoxolone

    Newsletter Article 12 February 2013 Pages: 4 - 4

12. Chemotherapy

    Newsletter Article 12 February 2013 Pages: 4 - 4

13. Cimetidine/ranitidine

    Newsletter Article 12 February 2013 Pages: 4 - 4

14. Cocaine abuse

    Newsletter Article 12 February 2013 Pages: 4 - 5

15. Contraceptives, oral

    Newsletter Article 12 February 2013 Pages: 5 - 5

16. Corticosteroids

    Newsletter Article 12 February 2013 Pages: 5 - 5

17. Cyclophosphamide

    Newsletter Article 12 February 2013 Pages: 5 - 5

18. Cyclosporin

    Newsletter Article 12 February 2013 Pages: 5 - 5

19. Deferoxamine

    Newsletter Article 12 February 2013 Pages: 5 - 5

20. Desipramine

    Newsletter Article 12 February 2013 Pages: 5 - 5

21. Diclofenac/indomethacin

    Newsletter Article 12 February 2013 Pages: 5 - 6

22. Dopamine

    Newsletter Article 12 February 2013 Pages: 6 - 6

23. Enoxacin interaction

    Newsletter Article 12 February 2013 Pages: 6 - 6

24. Erythromycin see Carbamazepine interaction

    Newsletter Article 12 February 2013 Pages: 6 - 6

25. Etretinate

    Newsletter Article 12 February 2013 Pages: 6 - 6

26. Fenbufen see Enoxacin interaction

    Newsletter Article 12 February 2013 Pages: 6 - 6

27. Flecainide overdose

    Newsletter Article 12 February 2013 Pages: 6 - 6

28. Fluoxetine

    Newsletter Article 12 February 2013 Pages: 6 - 6

29. Furosemide

    Newsletter Article 12 February 2013 Pages: 6 - 6

30. Gentamicin

    Newsletter Article 12 February 2013 Pages: 6 - 6

31. Granulocyte-macrophage-colony stimulating factor

    Newsletter Article 12 February 2013 Pages: 7 - 7

32. H2-antagonists see Sucralfate

    Newsletter Article 12 February 2013 Pages: 7 - 7

33. Indomethacin

    Newsletter Article 12 February 2013 Pages: 7 - 7

34. Indomethacin see Diclofenac/indomethacin

    Newsletter Article 12 February 2013 Pages: 7 - 7

35. Iron overdose

    Newsletter Article 12 February 2013 Pages: 7 - 7

36. Lithium interaction

    Newsletter Article 12 February 2013 Pages: 7 - 7

37. Lofepramine

    Newsletter Article 12 February 2013 Pages: 7 - 7

38. Mefenamic acid see Lithium interaction

    Newsletter Article 12 February 2013 Pages: 7 - 7

39. Methotrexate

    Newsletter Article 12 February 2013 Pages: 7 - 7

40. Methotrexate interaction

    Newsletter Article 12 February 2013 Pages: 7 - 7

41. Methylphenidate

    Newsletter Article 12 February 2013 Pages: 7 - 7

42. Naproxen

    Newsletter Article 12 February 2013 Pages: 8 - 8

43. Nicardipine

    Newsletter Article 12 February 2013 Pages: 8 - 8

44. Nitrofurantoin

    Newsletter Article 12 February 2013 Pages: 8 - 8

45. Nizatidine

    Newsletter Article 12 February 2013 Pages: 8 - 8

46. Norfloxacin

    Newsletter Article 12 February 2013 Pages: 8 - 9

47. Oxytetracycline

    Newsletter Article 12 February 2013 Pages: 9 - 9

48. Paracetamol overdose

    Newsletter Article 12 February 2013 Pages: 9 - 9

49. Penicillamine

    Newsletter Article 12 February 2013 Pages: 9 - 9

50. Penicillin

    Newsletter Article 12 February 2013 Pages: 9 - 9